Nokia (NOKIA-SEK)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 88.98 |
|---|---|
| 52-week range | 54.26 – 163.20 |
| Return, 1 month / 3 months | −13.8% / +1.4% |
| Return, 1 year / 3 years | +51.9% / +164.8% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 56.7% |
| Worst drawdown (1 year) | -48.9% |
| Average daily value traded | 149.04M SEK |
| Dividend yield | 19.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nokia is a Finnish technology company based in Espoo that supplies telecommunications network equipment and related software to mobile operators, cable providers and enterprises around the world. Its main business covers mobile and fixed network infrastructure, including radio access equipment, optical networks and core network systems, alongside a patent licensing arm that earns royalties from handset makers using its technology. Nokia also provides network management software and services that help customers build and run their communications networks.
Nokia trades under the code NOKIA-SEK on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nokia (NOKIA-SEK) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 88.98 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 325 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.9% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -44.8% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | -10.5% | ||
| 12-month return, skipping the last month | 76.2% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.9% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 149.04M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 19.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −13.8% |
| 3 months | +1.4% |
| 6 months | −10.5% |
| 1 year | +51.9% |
| 3 years | +164.8% |
| 5 years | +101.0% |
Signals
| 50-day / 200-day average | 98.90 / 96.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jul 2026 | EUR 0.4456 |
| 27 Apr 2026 | EUR 0.4456 |
| 2 Feb 2026 | EUR 0.3342 |
| 27 Oct 2025 | EUR 0.3342 |
| 28 Jul 2025 | EUR 0.4456 |
| 2 May 2025 | EUR 0.4456 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.